about
Oriental Medicine Samhwangsasim-tang Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Th1 Cell Responses and Upregulating Treg Cell Responses.Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathwaysThe regulatory effect of liuwei dihuang pills on cytokines in mice with experimental autoimmune encephalomyelitis.Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression.TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or NatalizumabCitrullination of histone H3 interferes with HP1-mediated transcriptional repression.Effects of coenzyme Q10 on the ratio of TH1/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL/6.Interleukin-10 and interleukin-12 modulation in patients with relapsing-remitting multiple sclerosis on therapy with interferon-beta 1a: differences in responders and non responders.3G11 expression in CD4+ T cell-mediated autoimmunity and immune toleranceEndoplasmic reticulum stress in disorders of myelinating cells.A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs.Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferon-γ.Stimulation of adult oligodendrogenesis by myelin-specific T cellsCCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients.Conditioned medium from gerbil--mouse T cell heterohybridomas improved antibody secretion.The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response.Family Analysis of Linkage and Association of HLA-DRB1, CTLA4, TGFB1, IL4, CCR5, RANTES, MMP9 and TIMP1 Gene Polymorphisms with Multiple SclerosisNatural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosisEarly intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.MicroRNA dysregulation in multiple sclerosis.Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gammaGlial connexins and gap junctions in CNS inflammation and disease.The role of chromogranin B in an animal model of multiple sclerosis.Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitisOxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis.Myelinated, synapsing cultures of murine spinal cord--validation as an in vitro model of the central nervous systemAdult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis.The therapeutic potential of interleukin-10 in neuroimmune diseases.Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cellsMultiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE modelsMyelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.
P2860
Q33571722-5980F8BF-BE65-46D8-B37E-AE04C9B3C1A9Q34027764-12C94708-7B39-43A3-A86A-9AD77AE0AC56Q34196541-36B7E4CF-7B53-491C-84FE-9733A9639756Q34238869-41B1706A-5C2D-4C38-9600-75958EB73A61Q34247796-69125AD1-1582-400C-97D5-DC79D04A1339Q34359908-0305B0E4-606C-4E66-8A1C-1637A64433DEQ34418098-7A1F6977-A17E-48AD-8B80-E8B42440D8BDQ34426561-7FF39D1A-8A65-4A06-AEF0-56CEA900A31AQ34475830-C7BC5036-2A92-4C6D-B0EC-3C7879D5D31EQ34805270-C3B37828-9C1D-4A02-9ACA-95A21E01FB67Q34810896-AF096A56-D627-440D-AE9B-B67F328E1B6BQ34962824-9173DC67-1EC8-4447-92B0-4956265D8E95Q34990282-411DD879-FF94-42D4-BA52-00B9159F723BQ35015387-C4D47AD0-D57A-4385-BF96-1F934F7558E5Q35235842-2295F063-2A5D-4CAF-82B7-5EDD57FCCD77Q35367491-6149F136-53EA-4455-8569-80A887EA71C6Q35594402-44056C3F-ACE3-49AD-BB96-B499F0465C7AQ35613472-8EA01ED7-D07D-4B74-B358-F23DAF518EEAQ35846548-59280809-5B99-4CB9-B2FF-AF3C607B3F7AQ35944470-4531BEA4-ECAB-431E-8D81-F0E5F494A1D0Q36166679-988A6546-4411-4045-9F72-4D9BAA2D79B6Q36187725-EF55A074-5066-4046-9BCF-329241F3E976Q36551019-97C05E45-E32F-4FD8-9881-17FCDCF957EAQ36598097-F0A30A1B-E415-48EB-BA0D-BCA9E6501D0BQ36734084-AFC9BFC6-10C4-45F8-8D7D-B6A2079721B8Q36735162-F0C6664B-6B85-4ACA-9378-88799E1B69C2Q36798405-FD2C88BC-FF67-41DB-9BD1-BEB981B60A7BQ36829238-8312F117-CD35-4C59-986F-E4F21DD5C31BQ36943108-66A4B026-55AE-4AD7-9A82-BD25C1D8E766Q37111630-8D66D857-0779-44C3-A459-9541A5CF81DEQ37216886-5EBAFA40-07DE-449C-827E-DBFD6355F5E5Q37228420-A3803B05-AC96-459D-B596-E17139C8AAEAQ37258085-EB1F47C5-A1F9-481E-B38A-9CF9BA4E9438Q37327995-81E89287-DAC8-4AC9-9F59-7A9FF66CA2EBQ37420758-F979CDF0-F9CF-4075-80DF-EA72FF32490FQ37452238-1DA503E9-5831-4B68-A1AE-7A40DBC8FF69Q37485007-3E5E88A2-1F36-4A9D-BF73-4B4665B4A813Q37571776-65955450-9509-48F5-A662-E707C6FA976EQ37601317-F8262B03-BAC8-45A4-8006-51B9B8C86833Q38154145-D59162B2-4A06-4D88-B6A4-EDA77A0E1882
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cytokines in multiple sclerosis: from bench to bedside.
@ast
Cytokines in multiple sclerosis: from bench to bedside.
@en
type
label
Cytokines in multiple sclerosis: from bench to bedside.
@ast
Cytokines in multiple sclerosis: from bench to bedside.
@en
prefLabel
Cytokines in multiple sclerosis: from bench to bedside.
@ast
Cytokines in multiple sclerosis: from bench to bedside.
@en
P1476
Cytokines in multiple sclerosis: from bench to bedside.
@en
P2093
Jaime Imitola
P304
P356
10.1016/J.PHARMTHERA.2004.11.007
P577
2005-01-11T00:00:00Z